The evaluation discusses 58 peptides in several clinical phases, indicating a robust pipeline of peptide therapies targeting PPIs. Improved Body Composition: This synergistic approach may well bring on major enhancements in muscle mass and reductions in system Excess fat share. Latest decades have observed a surge in clinical trials focusing